Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124779 | SCV000168218 | benign | not specified | 2014-02-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Clinical Services Laboratory, |
RCV000360398 | SCV000480331 | uncertain significance | Hyper-IgE syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000560845 | SCV000645709 | benign | Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive | 2017-12-29 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000124779 | SCV000967079 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Glu1737Glu in exon 40 of DOCK8: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 2.5% (111/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs34098809). |